11.02.2024 Views

YSM Issue 96.4

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Medicine<br />

FOCUS<br />

Alcoholism<br />

has a substantial<br />

impact on both mental and<br />

physical health and can present different<br />

features among affected individuals. Due to<br />

this, the mechanisms and possible causes of<br />

alcoholism cannot be as easily identified as<br />

diseases such as hemophilia, which presents<br />

clear physical symptoms. But in the decades<br />

since Angier’s article, scientists have made<br />

strides in figuring out the mystery of what<br />

really underlies this unique disease.<br />

Searching for AUD in Our Genes<br />

In 1990, an initially promising study of the<br />

genetic basis of alcoholism was conducted by<br />

Kenneth Blum, a professor at the University<br />

of Texas Health Science Center. The study<br />

found that there was a very strong connection<br />

between the D2 dopamine receptor gene and<br />

the development of alcoholism or problematic<br />

drinking behaviors. In their patient sample,<br />

the researchers found that in those with AUD,<br />

all had a higher frequency of one specific allele<br />

in the dopamine D2 receptor gene, suggesting<br />

that it was strongly associated with AUD.<br />

However, one year later, Joel Gelernter, a<br />

professor of genetics and neuroscience at the<br />

Yale School of Medicine, along with his team<br />

could not find the association between the D2<br />

dopamine receptor gene and AUD, showing a<br />

lack of replicability in the earlier study.<br />

While the D2 dopamine receptor gene did<br />

not have the effect expected on alcoholism,<br />

the study contributed to moving forward<br />

genetic research. “We know now that it was<br />

only a first step of a very long road of complex<br />

genetics,” said Renato Polimanti, a colleague<br />

of Gelernter at the Yale School of Medicine.<br />

In contrast to Angier’s conclusion that AUD<br />

is decided by the environment, scientists have<br />

since found multiple genetic players.<br />

The effort to uncover the genetic mysteries of<br />

AUD was—and is—long from over. Between<br />

the D2 dopamine receptor findings in the<br />

1990s and 2020, researchers have identified<br />

more than a dozen variants for AUD. In 2020, a<br />

research team including Gelernter, Polimanti,<br />

and Hang Zhou, an assistant professor of<br />

psychiatry at Yale, was able to greatly expand<br />

upon previous findings regarding alcoholism<br />

through a genome-wide association study<br />

published in Nature Neuroscience.<br />

www.yalescientific.org<br />

The team was able to identify twenty-nine<br />

genes linked to increased risk of problematic<br />

alcohol use—nineteen of them novel—in the<br />

human genome, extending the known genetic<br />

architecture of the disorder and giving other<br />

scientists a wider breadth of targets for followup<br />

studies. Researchers found that six to<br />

eleven percent of the phenotypic variation—<br />

referring to differences in what physical and<br />

behavioral traits are expressed—could be<br />

explained by genetic information.<br />

The goal of genetic studies, however, is<br />

not only to find associations but also to<br />

understand how these variants might promote<br />

the development of AUD. In their study,<br />

the Yale team discovered that the risk genes<br />

were correlated to changes in certain brain<br />

regions. This finding suggested to researchers<br />

that the risk variants promoted certain brain<br />

pathways that contribute to the development<br />

of behavior patterns and disorders.<br />

Such pathways are not exclusive to AUD.<br />

The researchers discovered a strong genetic<br />

correlation between problematic alcohol<br />

use and 138 other conditions, including<br />

substance abuse disorders, depression, and<br />

schizophrenia. “AUD has many variants<br />

across the genome that are involved in the<br />

predisposition of this trait, but these variants<br />

are not only predisposing to AUD, they are<br />

predisposing to many things,” Polimanti<br />

said. “It can depend on where [risk variants]<br />

play a role, maybe in sensitivity to a<br />

substance, or to addiction pathways in the<br />

brain, or to reward systems.”<br />

Moving Forward<br />

This research does not mean AUD is solely<br />

explained by genetics. Rather, in AUD, only<br />

about fifty percent of the risk appears to be<br />

attributed to our genes. This is relatively<br />

ABOUT THE<br />

AUTHORS<br />

small in comparison to schizophrenia,<br />

where genetics can explain eighty percent<br />

of the disease predisposition. Therefore, as<br />

research progresses, consideration must<br />

still be made for the environment—the<br />

“nurture”—that individuals were raised and<br />

live in. “Genetic variants among individuals<br />

cannot explain everything. We need to<br />

spend more time in gene discovery before<br />

bringing it into patient care,” Zhou said.<br />

Beyond addressing the nature versus<br />

nurture debate, this research has a broader<br />

aim. According to Polimanti and Zhou,<br />

geneticists hope to be able to bring their<br />

findings to human healthcare in order to<br />

help predict and treat certain illnesses. This is<br />

called precision medicine, wherein a person’s<br />

treatment plan can be specially tailored based<br />

on their unique genetic makeup.<br />

Until we get there, research will continue<br />

focusing on identifying genetic variants and<br />

possible mechanisms behind risk. Polimanti<br />

explained that for certain illnesses like<br />

cardiovascular disease, the field of genetics<br />

is expected to transform treatments in the<br />

coming years. “We will keep doing gene<br />

discovery and use increasingly advanced<br />

technology to deliver this information and get<br />

a deeper understanding of the role genetics<br />

play in human health,” Zhou said.<br />

The study of AUD has been marked<br />

by both successes and failures. Now, we<br />

enter an exciting time where genetic and<br />

environmental studies promise great strides<br />

for the understanding of our human genome<br />

and real changes in clinical care. Nature and<br />

nurture, instinctivists and environmentalists,<br />

the D2 dopamine receptor and twenty-nine<br />

other discovered genes, and, now, precision<br />

medicine, are all important themes in the<br />

long and evolving story of alcoholism and<br />

scientific discovery. ■<br />

MATTHEW BLAIR<br />

LEA PAPA<br />

MATTHEW BLAIR is a sophomore in Benjamin Franklin College from Manchester, NH, majoring in<br />

the History of Science, Medicine, and Public Health. In addition to copy editing for <strong>YSM</strong>, Matthew<br />

conducts lung cancer research in the Schalper Lab at the Yale School of Medicine and plays for the<br />

club ice hockey team.<br />

LEA PAPA is a sophomore in Ezra Stiles College from South Milwaukee, WI, studying neuroscience.<br />

Outside of <strong>YSM</strong>, Lea is involved in Yale’s Questbridge Chapter, is working towards becoming an EMT,<br />

and recently joined the Yale Undergraduate Research Journal Humanities Committee.<br />

THE AUTHORS WOULD LIKE TO THANK Renato Polimanti and Hang Zhou for their time and expertise.<br />

December 2023 Yale Scientific Magazine 15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!